Levetiracetam Beta

Levetiracetam, the active ingredient in Levetiracetam Beta, is an antiepileptic presented as an oral formulation for oral use. It treats partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients requiring seizure control.

GNH USA supplies Levetiracetam Beta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic agent that modulates neuronal excitability in various seizure disorders. - Partial‑onset seizures: reduces seizure frequency in patients with focal epilepsy. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes in generalized epilepsy. - Myoclonic seizures: decreases myoclonic jerks in appropriate seizure types.

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects: - Dizziness - Fatigue - Somnolence - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Blood dyscrasias such as agranulocytosis - Suicidal thoughts or behavior - Severe skin rash - Hepatic dysfunction

When prescribing levetiracetam, clinicians should consider several safety aspects. - Renal impairment: dose may need adjustment in patients with reduced kidney function. - Psychiatric symptoms: monitor for mood changes, depression, or aggression. - Concomitant CNS depressants: use caution as additive sedation may occur. - Pregnancy: safety not established; assess risk versus benefit. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Levetiracetam can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: may decrease efficacy of levetiracetam. - Phenytoin: may lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Alcohol: can enhance central nervous system depression. - Other antiepileptics: may require dose adjustments. - Renal excretion inhibitors: monitor renal function and consider dose modification.